USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Pricing and Reimbursement Issues for Generics & Biosimilars Markets in Europe
28-Dec-2006
Europe
Market Research
B796-01-00-00-00
HC01173-EU-MR_05270
This research highlights the various issues affecting the pricing and reimbursement environment for generics in Europe. It includes an overview of the generics market, key trends, country-wise market trends, list of market participants, strategic suggestions and decision support databases.
Executive Summary
- Executive Summary
Important Terms
- Definitions
Pricing and Reimbursement Issues for Generics & Biosimilars Markets in Europe , Research Methodology
Methodology Of Research
- The "12 Step" Market Engineering Research Methodology and Process
Overview
- Market Analysis
- Scope and Objectives
- Pricing and Reimbursement
- The Biosimilars Opportunity
Pharmaceutical Cost-containment Measures
- Reference Pricing
- Parallel Trade
- Generic Substitution
- Patient Co-payments and Reimbursement
Political/Legal/Regulatory Issues
- Impact of EU Accession
- The Roche/Bolar Provision
- Data Exclusivity and Marketing Authorisation Applications
Group I
Group II
- Denmark
- Germany
- The Netherlands
- The United Kingdom
Group III
- Austria
- Belgium
- France
- Italy
- Portugal
- Spain
Market Players
Recommendations to Market Participants
DSDs
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
16 Oct 2026 | Global | Market Research
Public Sector Healthcare Cloud Market, North America and Europe, 2026
Public healthcare organizations across North America and Europe are using cloud technologies to support modernization efforts that extend beyond infrastructure replacement. Cloud is increasingly being adopted to improve interoperability, enable secure data sharing, support analytics and AI initiativ...
16 Oct 2026 | Global | Technology Research
Innovations and Growth Opportunities in Precision Therapeutics, AI-Enabled Discovery and Bioengineering, Regenerative Medicine, and Next-Generation Vaccine Platforms
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming precision therapeutics, regenerative medicine, AI-enabled discovery, laboratory automation, targeted delivery, vaccines, and biomanufactu...
15 Oct 2026 | Global | Frost Radar
Frost Radar™: US and European Mammalian Contract Development and Manufacturing Organizations, 2026
The US and European mammalian contract development and manufacturing organization (CDMO) market is entering a new phase of strategic evolution, driven by accelerating biologics outsourcing, increasing molecule complexity, and growing demand for resilient, end-to-end manufacturing partnerships. As mo...
08 Oct 2026 | Global | Frost Radar
Frost Radar: Endoscopy Device Technology Ecosystem, 2026
The endoscopy device market is advancing toward higher-quality visualization and improved clinical decision-making, with innovation across 4K ultrahigh-definition display systems, image-enhanced endoscopy, and computer-aided detection systems. Advanced visualization is evolving through improvements ...
07 Oct 2026 | Global | Technology Research
Growth Opportunities in Image-Guided Cancer Ablation Systems
Image-guided cancer ablation systems are minimally invasive medical technologies that use real-time imaging to accurately guide the placement of an ablation device into a tumor, enabling localized destruction of cancerous tissue while minimizing damage to surrounding healthy structures.The increasin...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | Yes |
| Podcast | No |
| Industries | Healthcare |
| WIP Number | B796-01-00-00-00 |
| Is Prebook | No |
Pricing and Reimbursement Issues for Generics & Biosimilars Markets in Europe
$4,950.00
Special Price $3,712.50 save 25 %